|
|
Acutus Medical Inc (AFIB) |
|
Price: $0.0575
$-0.01 
-17.857%
|
| Day's High:
| $0.06
| Week Perf:
| 0.88 %
|
| Day's Low: |
$ 0.06 |
30 Day Perf: |
-2.54 % |
| Volume (M): |
30 |
52 Wk High: |
$ 0.28 |
| Volume (M$): |
$ 2 |
52 Wk Avg: |
$0.10 |
| Open: |
$0.06 |
52 Wk Low: |
$0.03 |
|
|
| Market Capitalization (Millions $) |
2 |
| Shares
Outstanding (Millions) |
30 |
| Employees |
70 |
| Revenues (TTM) (Millions $) |
51 |
| Net Income (TTM) (Millions $) |
-42 |
| Cash Flow (TTM) (Millions $) |
-19 |
| Capital Exp. (TTM) (Millions $) |
0 |
Acutus Medical Inc
Acutus Medical Inc is a medical technology company that focuses on developing and commercializing advanced solutions for complex cardiac arrhythmias. The company specializes in the field of electrophysiology, which deals with the diagnosis and treatment of irregular heart rhythms.
Acutus Medical's flagship product is the AcQMap System, which offers high-resolution, real-time imaging of the heart and provides detailed three-dimensional maps of the cardiac chamber. This technology enables doctors to accurately identify and target the source of arrhythmias during procedures like catheter ablation.
The company aims to improve patient outcomes and enhance the efficiency of cardiac ablation procedures through their innovative technology. It also collaborates with leading medical centers and researchers to advance the understanding and treatment of cardiac arrhythmias.
Overall, Acutus Medical Inc is dedicated to advancing the field of electrophysiology and providing clinicians with the tools they need to deliver personalized cardiac care.
Company Address: 2210 Faraday Ave. Carlsbad 92008 CA
Company Phone Number: 232-6080 Stock Exchange / Ticker: AFIB
|
|
|
|
|
|
|
| Stock Performances by Major Competitors |
|
|
|
| Acutus Medical Inc
A Closer Look at Acutus Medical, Inc.: Bearish Indicators Emerge Amid Insufficient Revenue Growth
Acutus Medical, Inc., a company known for its development of medical equipment and supplies, recently disclosed its revenue figures for the fiscal second quarter of 2024. The reported revenue amounting to $3.657 million signals a precarious financial position. While the company's net loss of $0.914 million appears to be an improvement compared to the staggering $18.346 million loss from the previous year, the underlying metrics suggest a company struggling to maintain viability in an increasingly competitive healthcare landscape. Coupled with the year-to-date performance of its shares, which have significantly lagged behind the broader market, there are several reasons to adopt a bearish outlook on Acutus Medical's future.
Weak Revenue Growth Raises Concerns
First and foremost, the revenue figures for the second quarter of 2024 show minimal sign of growth. At $3.657 million, the company?s revenue appears meager when juxtaposed with the operational costs and the broader market?s growth trajectory. While the improved net loss offers a semblance of progress, a loss of nearly $1 million is still a considerable burden, especially for a company that relies heavily on consistent revenue growth to sustain its operations and inspire investor confidence. The healthcare sector, especially medical equipment, is thriving, yet Acutus Medical's inability to capitalize on this trend raises red flags.
|
| Acutus Medical Inc
Acutus Medical Inc has recently reported their financial results for the first quarter of 2024 earnings season, showing some significant improvements compared to the previous year. Although the company still reported a loss per share of -$0.06, this is a significant improvement from the loss of -$0.57 per share a year ago. Additionally, the company's income per share also saw an improvement from -$1.16 in the preceding quarter.
On the downside, Acutus Medical Inc saw a decrease in revenue, with the revenue crumbling by -28.777% to $2.97 million from $4.17 million in the same quarter a year ago. There was also a significant sequential drop in revenue by -92.544% from $39.83 million. However, despite the decrease in revenue, the company reported a lower net deficit of -$1.620 million, compared to a deficit of -$16.315 million in the same quarter a year ago.
|
| Acutus Medical Inc
Headline: Acutus Medical Inc Reports Solid Revenue Improvement but Faces Concerns Over Future Performance
Acutus Medical Inc, a prominent player in the Medical Equipment & Supplies sector, recently announced an exceptional financial performance in the fourth quarter of 2023, showcasing a substantial revenue improvement of 702.781% year on year. Despite this remarkable achievement, investors are wary as the company recorded a loss per stock at $-1.16.
The company's revenue improvement in the fourth quarter of 2023 outshone its sector peers, who reported an average business improvement of 10.11% during the same period. In comparison to the preceding reporting season, Acutus Medical Inc experienced an increased loss from $-0.45 per share, while revenue doubled by 757.937% from $4.64 million.
|
| Acutus Medical Inc
Acutus Medical Inc, a medical equipment and supplies company, has shown some noteworthy developments in its financial performance for the fiscal span ending on September 30, 2023. Despite experiencing a net deficit of $13.237 million, the company managed to decrease its loss per share to $-0.45 compared to $-0.72 in the previous year. This improvement in the loss per share was accompanied by an increase in revenue of 27.415%, reaching $4.64 million from $3.64 million in the comparable reporting season a year ago.
The positive growth in revenue indicates that Acutus Medical Inc's performance in the third quarter of 2023 is favorably correlated with its industry peers in the Medical Equipment & Supplies sector, which collectively witnessed a 4.80% increase in top-line revenue during the same period. This demonstrates Acutus Medical Inc's ability to navigate the market successfully amidst competitive pressures.
|
| Acutus Medical Inc
The stock market is an ever-changing landscape, reflecting the performance and future prospects of various companies. Acutus Medical Inc, a medical technology company specializing in cardiac mapping and ablation systems, recently released its second-quarter earnings for 2023. The results indicate a significant loss per share compared to the previous year and a decline from the preceding quarter. This article will delve into the interesting facts from Acutus Medical Inc's earnings report and analyze the implications for investors and the company's potential.
Decrease in Earnings:
During the second quarter of 2023, Acutus Medical Inc recorded a loss per share of $-0.63, a substantial decline from the $0.16 per share profit generated in the same period the previous year. Furthermore, this reflects a downturn from the preceding quarter's loss per share of $-0.57. The declining trend presents a concerning outlook for the company's profitability and operational efficiency.
|
| Per Share |
Current |
| Earnings (TTM) |
-1.44 $ |
| Revenues (TTM) |
1.71 $
|
| Cash Flow (TTM) |
- |
| Cash |
0.42 $
|
| Book Value |
-
|
| Dividend (TTM) |
0 $ |
|
|
| Per Share |
|
| Earnings (TTM) |
-1.44 $
|
| Revenues (TTM) |
1.71 $ |
| Cash Flow (TTM) |
- |
| Cash |
0.42 $
|
| Book Value |
- |
| Dividend (TTM) |
0 $ |
|
|
| |
| Disposables |
|
 120.45 % |
of total Revenue |
|
|
